What Researchers Did
This review summarized recent studies on the management of radiation retinopathy and maculopathy, common complications following plaque brachytherapy for choroidal melanoma.
What They Found
Researchers found that intravitreal bevacizumab, triamcinolone, and laser photocoagulation transiently reduced macular oedema, but visual acuity improvements were limited. Sustaining these effects often required recurrent treatments. While some case studies showed positive results for photodynamic therapy, oral pentoxyphylline, and hyperbaric oxygen, further research is needed.
What This Means for Canadian Patients
Canadian patients undergoing plaque brachytherapy for choroidal melanoma should be aware that current treatments for radiation retinopathy offer only transient benefits with limited visual improvement. These treatments often require frequent administration to maintain any positive effects.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
A significant limitation is the current lack of proven, consistently effective treatments for radiation retinopathy or maculopathy, necessitating further research.